Randomized Open-Label Phase II Study of Decitabine in Patients With Low- or Intermediate-Risk Myelodysplastic Syndromes. | Aplastic Anemia and MDS International Foundation

Randomized Open-Label Phase II Study of Decitabine in Patients With Low- or Intermediate-Risk Myelodysplastic Syndromes.

Journal Title: 
J Clin Oncol
Author(s): 
Garcia-Manero G, Jabbour E, Borthakur G, Faderl S, Estrov Z, Yang H, Maddipoti S, Godley LA, Gabrail N, Berdeja JG, Nadeem A, Kassalow L, Kantarjian H.
Primary Author: 
Garcia-Manero G
Original Publication Date: 
Monday, June 3, 2013

No abstract available.

Bone Marrow Diseases: